Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs

Pfizer deals again in obesity space as Wave and Structure drop splashy weight loss results; what CDER Director Richard Pazdur’s sudden retirement means for biopharma; neuro diseases take center stage at CTAD; and more.